(888) 552-6760 SCHEDULE AN APPOINTMENT

Alexander Chehrazi-Raffel,

Medical Oncologist

Biography photo
Location
Duarte Comprehensive Cancer Center
1500 East Duarte Road
Duarte, CA 91010
Education
Medical school:
Board Certifications
  • 2022-present, ABIM Medical Oncology
  • 2022-present, ABIM Hematology
  • 2019-present, ABIM Internal Medicine
Degrees
  • 2016, Doctor of Medicine, Chicago Medical School, North Chicago, Illinois
  • 2007, Bachelor of Arts, University of Pennsylvania, Philadelphia, Pennsylvania
Fellowship

2022, Fellowship, Hematology/Oncology, City of Hope/Harbor-Medical Center, Duarte, California

Residency

2019, Internal Medicine, Harbor-UCLA Medical Center, Torrance, California

Professional Experience

2022-present, Assistant Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, California

Academic Appointments
  • Assistant Professor, Department of Medical Oncology & Therapeutics Research
About Me

Medical oncologist Alexander Chehrazi-Raffle, M.D., has always had an interest in medicine. As a highschooler he was inspired to become a physician when he shadowed doctors and saw firsthand the tremendous impact that physicians have on people’s lives. Dr. Chehrazi-Raffle specializes in caring for patients with genitourinary cancers and aims to provide a patient-centered experience where people play an active role in developing a treatment plan uniquely tailored to their needs. His goal in providing care is to educate, counsel and advocate for patients with the hope of improving patient outcomes and establishing a trusted bond that will endure for years to come. 

Dr. Chehrazi-Raffle has published more than a dozen peer-reviewed case studies and research papers. As a City of Hope fellow, he became co-investigator on four ongoing clinical trials when he joined the faculty. His work on a precision medicine study to help predict treatment success in patients with advanced kidney cancer was published in the Journal of Immunotherapy of Cancer and garnered a merit award at the International Kidney Cancer Symposium.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.